MREONasdaq United Kingdom
Market cap
$45.970 M
$0.30 -3.14%
Close of 7 Aug 2026
Revenue
$500.0K
#3556 by revenue
Earnings
$41.9M
#1641 by earnings
Shares outstanding
798,078,829
Latest filing cover page
P/E ratio
1.1
Cap ÷ net income
Where these numbers come from
Share counts and financials for Mereo BioPharma Group are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.